ADTHYZA (THYROID TABLETS, USP)
LIVE

Serial Number

97538981

Owner

AZURITY PHARMACEUTICALS, INC.

Attorney

Elizabeth Fox

First Use Date

Feb 21, 2023

Filing Date

Aug 8, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ADTHYZA (THYROID TABLETS, USP) Trademark

Serial Number: 97538981 • Registration: 7116955

ADTHYZA (THYROID TABLETS, USP) is a trademark filed by AZURITY PHARMACEUTICALS, INC. on August 8, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

AZURITY PHARMACEUTICALS, INC. (89 trademarks)

WOBURN, MA 01801

Entity Type: 03

Trademark Details

Filing Date

August 8, 2022

Registration Date

July 18, 2023

First Use Anywhere

February 21, 2023

First Use in Commerce

February 21, 2023

Published for Opposition

February 14, 2023

Goods & Services

Pharmaceutical preparations for the treatment of hypothyroidism

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Mar 19, 2025 ASCK
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 18, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 18, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 16, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 15, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 23, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 22, 2023 AITU
USE AMENDMENT FILED
May 1, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
May 1, 2023 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 11, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 14, 2023 NPUB
PUBLISHED FOR OPPOSITION
Feb 14, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 25, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 11, 2023 CNSA
ASSIGNED TO EXAMINER
Jan 10, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 30, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 28, 2022 NWOS
NEW APPLICATION ENTERED
Aug 11, 2022 NWAP